Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jean Francois Thebaut"'
Autor:
Philippe Loirat, Jean-Francois Thebaut, Geneviève Derumeaux, Catherine Grenier, Francois Schiele, Armelle Desplanques-Leperre, Frédéric Capuano, Christine Gardel
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 6:50-57
Background— In acute myocardial infarction, the relationship between volume and quality indicators (QIs) is poorly documented. Through a nationwide assessment of QIs at discharge repeated for 3 years, we aimed to quantify the relationship between v
Autor:
P. Guéret, A. Desplanques-Leperre, Nicolas Danchin, M. Erbault, N. Riolacci, L. Banaei, Jean-Francois Thebaut
Publikováno v:
Archives des Maladies du Coeur et des Vaisseaux - Pratique. 2009:32-34
Autor:
Francois Schiele, Armelle Desplanques-Leperre, Christine Gardel, Laurent Degos, Jean-Francois Thebaut
Publikováno v:
Journal of the American College of Cardiology. 57:E1274
Autor:
Patrick Assyag, Pascal Poncelet, Maxime Guenoun, Alain Cohen Solal, Christine Contre, Pierre Louis Prost, Leurs Irina, Jean Francois Thebaut
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 2:28
RationaleHF treatment is often started during hospitalisation. It appeared interesting to describe the evolution of treatment after hospital discharge.ObjectivesTo describe changes in HF treatment since hospital discharge after stratification on the
Autor:
Pascal Poncelet, Maxime Guenoun, Alain Cohen Solal, Patrick Assyag, Leurs Irina, Jean Francois Thebaut, Pierre Clerson, Christine Contre
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 2:31
Rationale Heart Failure (HF) with preserved LVEF has been individualized in recent years as a specific entity, with different mechanisms, special baseline characteristics, a poor prognosis and no clearly recognized treatment. LVEF cut-off has not bee
Autor:
Christine Contre, Pierre Clerson, Alain Cohen Solal, Leurs Irina, Jean Francois Thebaut, Maxime Guenoun, Pascal Poncelet, Patrick Assyag
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):35-36
Rationale The part of elderly patients (pts) in heart failure (HF) population is growing. They might pose specific problems due to the greater proportion of HF with preserved LVEF, more frequent comorbidities or contra-indications to recommended HF t
Autor:
Christine Contre, Maxime Guenoun, Jean Francois Thebaut, Pierre Louis Prost, Patrick Assyag, Pascal Poncelet, Leurs Irina, Alain Cohen Solal
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):29-30
Rationale Beta blockers are a corner stone treatment of heart failure (HF) in patients with altered systolic function (LVEF 50%) or for patients belonging to the “grey zone” (LVEF 40-50%). Objectives to describe the prescription rate of beta-bloc
Autor:
Pascal Poncelet, Maxime Guenoun, Pierre Clerson, Patrick Assyag, Alain Cohen Solal, Jean Francois Thebaut, Leurs Irina, Christine Contre
Publikováno v:
Archives of Cardiovascular Diseases Supplements. (1):30
Rationale Heart failure (HF) treatment is often started during hospitalisation and patients are generally taken over after discharge by outhospital cardiologists. Objectives To describe changes in HF treatment implemented by the outhospital cardiolog